Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MICE versus fine needle diathermy for corneal neovascularization
PACTR202602897516823Phase 4Completed
- Sponsor
- Dr. Reem Dessouky
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of mitomycin c in corneal neovascularization (CNV) (2 arms), sponsored by Dr. Reem Dessouky. Started Oct 2024; status: completed.
02
Drugs
mitomycin c
03
Conditions
corneal neovascularization (CNV)
Beyond the preview
Go deeper on PACTR202602897516823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202602897516823.